The airway epithelium in health and disease: calm on the surface, paddling furiously underneath

Thorax

Volumn 64, Issue 4, 2009, Pages 277-278

  Smyth, Rosalind L ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 5; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; SIGNAL PEPTIDE;

ASTHMA; B LYMPHOCYTE; BRONCHIOLITIS; CELL PROLIFERATION; CILIATED EPITHELIUM; DENDRITIC CELL; EDITORIAL; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; T LYMPHOCYTE; VIRUS INFECTION; BRONCHITIS; BRONCHUS; CYTOLOGY; EPITHELIUM; EPITHELIUM CELL; IMMUNOLOGY; NOTE; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

BRONCHI; BRONCHITIS; EPITHELIAL CELLS; EPITHELIUM; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RESPIRATORY MUCOSA;

EID: 64849109062     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.099630     Document Type: Editorial

References (15)

1. Cruickshank SM, McVay LD, Baumgart DC, et al. Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut 2004;53:678-84.
2. Wang H, Su Z, Schwarze J. Healthy, but not RSVinfected, lung epithelial cells profoundly inhibit T-cell activation. Thorax 2009;64:283-90.
3. Raz E. Organ-specific regulation of innate immunity. Nat Immunol 2007;8:3-4.
4. Mayer AK, Muehmer M, Mages J, et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol 2007;178:3134-42.
5. Melmed G, Thomas LS, Lee N, et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003;170:1406-15.
6. Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004;114:270-9.
7. Mayer AK, Bartz H, Fey F, et al. Airway epithelial cells modify immune responses by inducing an antiinflammatory microenvironment. Eur J Immunol 2008;38:1689-99.
8. McNamara PS, Flanagan BF, Selby AM, et al. Proand anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 2004;23:106-12.
9. McNamara PS, Flanagan BF, Baldwin LM, et al. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 2004;363:1031-7.
10. Fletcher JN, Smyth RL, Thomas HM, et al. Respiratory syncytial virus genotypes and disease severity among children in hospital. Arch Dis Child 1997;77:508-11.
11. McNamara PS, Flanagan BF, Hart CA, et al. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005;191:1225-32.
12. McNamara PS, Ritson P, Selby A, et al. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003;88:922-6.
13. McNamara PS, Smyth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002;61:13-28.
14. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-47.
15. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006;12:1023-6.